Precose (acarbose) reduces the risk of heart disease in patients with "pre-diabetes"

September 2003

New evidence suggests Precose (acarbose) reduces the risk of heart disease in patients with "pre-diabetes."

These patients have impaired glucose tolerance and are at risk for developing both diabetes and heart disease.

Precose seems to help. But you need to treat 20 patients for 3 years to prevent one case of hypertension...or 40 patients to prevent one case of heart disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote